HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.400
+0.000 (0.07%)
Apr 29, 2026, 10:28 AM EDT - Market open
HCW Biologics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3 | 3 | 20 | 44 | 69 | 83 | |
| Market Cap Growth | -73.86% | -86.80% | -54.91% | -35.84% | -17.13% | - | |
| Enterprise Value | 8 | 8 | 32 | 39 | 49 | 43 | |
| Last Close Price | 0.40 | 0.97 | 17.84 | 49.00 | 76.59 | 92.80 | |
| PS Ratio | 49.67 | 48.35 | 7.74 | 15.51 | 10.22 | - | |
| PB Ratio | 0.47 | 0.95 | -2.93 | 3.27 | 1.84 | 1.62 | |
| P/TBV Ratio | 0.97 | 0.95 | - | 3.27 | 1.84 | 1.62 | |
| EV/Sales Ratio | 139.22 | 153.65 | 12.39 | 13.85 | 7.31 | - | |
| Debt / Equity Ratio | 2.46 | 2.46 | -2.02 | 0.48 | 0.18 | - | |
| Net Debt / Equity Ratio | 1.76 | 1.76 | -1.33 | 0.21 | -0.68 | -0.72 | |
| Net Debt / EBITDA Ratio | -0.38 | -0.38 | -0.33 | -0.12 | 1.76 | 2.86 | |
| Net Debt / FCF Ratio | -0.36 | -0.36 | -0.62 | -0.10 | 1.23 | 3.33 | |
| Asset Turnover | 0.00 | 0.00 | 0.09 | 0.08 | 0.13 | - | |
| Quick Ratio | 0.09 | 0.09 | 0.18 | 0.59 | 10.99 | 15.87 | |
| Current Ratio | 0.11 | 0.11 | 0.19 | 0.73 | 11.52 | 17.44 | |
| Return on Equity (ROE) | - | - | -897.37% | -98.23% | -33.63% | -39.22% | |
| Return on Assets (ROA) | -31.19% | -31.19% | -59.91% | -42.68% | -18.79% | -24.25% | |
| Return on Capital Employed (ROCE) | -395.20% | -395.20% | -4633.30% | -130.10% | -34.40% | -26.10% | |
| Earnings Yield | -827.83% | -303.55% | -151.10% | -56.72% | -21.69% | -15.52% | |
| FCF Yield | -497.16% | -510.70% | -72.92% | -65.16% | -30.08% | -13.30% | |
| Buyback Yield / Dilution | -116.30% | -116.30% | -7.97% | -0.30% | -90.84% | -296.07% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.